|
CA3085528A1
|
|
Nanoparticles for use for treating a neuronal disorder
|
|
BR112020012215A2
|
|
nanoparticles for use in improving brain performance or treating stress
|
|
US2019351231A1
|
|
Nanoparticles for use for treating a neuronal disorder
|
|
AU2017384538A1
|
|
Coated nanoparticles for use for modulating electrical polarization of neurons
|
|
AU2017384518A1
|
|
Nanoparticles for use for enhancing brain performances or for treating stress
|
|
BR112017025553A2
|
|
vaccine composition, and kit
|
|
CN107106505A
|
|
Pharmaceutical composition, its preparation and use
|
|
US2017258937A1
|
|
Pharmaceutical composition, preparation and uses thereof
|
|
WO2016083338A1
|
|
Pharmaceutical compositions, preparation and uses thereof
|
|
WO2016083333A1
|
|
Pharmaceutical composition, preparation and uses thereof
|
|
US2017258717A1
|
|
Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof
|
|
HUE043358T2
|
|
Compositions for use in oncology
|
|
CN105431141A
|
|
Compositions and methods for use in medical diagnosis
|
|
AU2014283232A1
|
|
Compositions and methods for use in oncology
|
|
NZ714273A
|
|
Pharmaceutical composition comprising the combination of a biocompatible nanoparticle and a compound of interest, preparation and uses thereof
|
|
KR20150108923A
|
|
Inorganic nanoparticles compositions in combination with ionizing radiations for treating cancer
|
|
HUE045407T2
|
|
Compositions comprising nanoparticles of hafnium (iv) oxide or rhenium (iv) oxide in combination with ionizing radiations for treating cancer
|
|
EP2886128A1
|
|
Pharmaceutical composition comprising nanoparticles, preparation and uses thereof
|
|
UA111474C2
|
|
Nanoparticles comprising metallic material covered with hafnium oxide material for producing therapeutic anticancer agent
|
|
MX2014007131A
|
|
Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof.
|
